Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4B |
| 2 |
TC Energy
TRP
|
+$1.99B |
| 3 |
Amazon
AMZN
|
+$1.97B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$1.83B |
| 5 |
NVIDIA
NVDA
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.57B |
| 2 |
Scotiabank
BNS
|
+$1.51B |
| 3 |
Enbridge
ENB
|
+$1.47B |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.02B |
| 5 |
Medtronic
MDT
|
+$871M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Financials | 9.2% |
| 3 | Consumer Discretionary | 8.28% |
| 4 | Communication Services | 6.4% |
| 5 | Healthcare | 6.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Establishment Labs
ESTA
$2.28B
| $15.3M | ﹤0.01% |
373,330
+266,893
| +251% | +$10.9M |
|
2527
iShares MSCI Europe Financials ETF
EUFN
$4.29B
| $15.3M | ﹤0.01% |
445,527
+5,276
| +1% | +$175K |
|
|
HNGE
2528
Hinge Health
HNGE
$7.21B
| $15.3M | ﹤0.01% |
311,713
+120,304
| +63% | +$6.29M |
|
2529
CALL
General Motors
GM
$76.8B
| $15.2M | ﹤0.01% |
250,000
+233,100
| +1,379% | +$13M |
|
2530
Crocs
CROX
$6.55B
| $15.2M | ﹤0.01% |
182,417
-91,057
| -33% | -$8.31M |
|
|
UCTT
2531
Ultra Clean Holdings
UCTT
$3.95B
| $15.2M | ﹤0.01% |
559,027
+356,934
| +177% | +$8.78M |
|
2532
Schwab US Mid-Cap ETF
SCHM
$15.1B
| $15.2M | ﹤0.01% |
512,014
+7,890
| +2% | +$230K |
|
2533
V2X
VVX
$2.65B
| $15.2M | ﹤0.01% |
261,170
+127,700
| +96% | +$6.83M |
|
2534
CALL
Valero Energy
VLO
$85.9B
| $15.2M | ﹤0.01% |
89,100
+84,000
| +1,647% | +$12.5M |
|
2535
Hawaiian Electric Industries
HE
$2.14B
| $15.2M | ﹤0.01% |
1,372,671
+274,652
| +25% | +$3.13M |
|
2536
Colliers International
CIGI
$5.19B
| $15.1M | ﹤0.01% |
96,955
-20,788
| -18% | -$3.2M |
|
2537
Willdan Group
WLDN
$1.3B
| $15.1M | ﹤0.01% |
156,629
+44,227
| +39% | +$4.19M |
|
2538
Northwest Natural Holdings
NWN
$2.12B
| $15.1M | ﹤0.01% |
336,991
+72,995
| +28% | +$3.03M |
|
2539
RXO
RXO
$3.58B
| $15.1M | ﹤0.01% |
984,360
-126,565
| -11% | -$2.04M |
|
2540
CRISPR Therapeutics
CRSP
$5.17B
| $15.1M | ﹤0.01% |
233,542
+12,942
| +6% | +$743K |
|
2541
PUT
Capital One
COF
$134B
| $15.1M | ﹤0.01% |
71,110
+21,000
| +42% | +$4.6M |
|
|
OPLN
2542
Openlane
OPLN
$4.54B
| $15.1M | ﹤0.01% |
525,211
+92,345
| +21% | +$2.52M |
|
2543
CALL
DraftKings
DKNG
$11.9B
| $15.1M | ﹤0.01% |
404,100
+8,000
| +2% | +$355K |
|
2544
CALL
KeyCorp
KEY
$24.4B
| $15.1M | ﹤0.01% |
808,600
| – | – |
|
|
2545
PUT
KeyCorp
KEY
$24.4B
| $15.1M | ﹤0.01% |
808,600
| – | – |
|
2546
CALL
Iris Energy
IREN
$14.7B
| $15.1M | ﹤0.01% |
322,000
-620,500
| -66% | -$15.1M |
|
|
ONC
2547
BeOne Medicines Ltd
ONC
$39.4B
| $15.1M | ﹤0.01% |
44,231
-26,024
| -37% | -$7.9M |
|
2548
PUT
BigBear.ai
BBAI
$1.57B
| $15.1M | ﹤0.01% |
+2,310,800
| New | +$14.8M |
|
|
AMWD
2549
DELISTED
American Woodmark
AMWD
| $15.1M | ﹤0.01% |
225,680
+173,534
| +333% | +$10.6M |
|
2550
Travel + Leisure Co
TNL
$4.7B
| $15.1M | ﹤0.01% |
252,997
-224,443
| -47% | -$13.5M |
|
Similar funds
Goldman Sachs's Q3 2025 Portfolio in Review
As of Q3 2025, Goldman Sachs held 6,765 positions worth $817B, up 11% from $736B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Goldman Sachs's Q3 2025 filing shows 707 new, 2,950 increased, 2,106 reduced and 470 closed positions. Its largest new stake was Fidelity Enhanced International ETF: 1,911,687 shares worth $67.4M. The largest sale was iShares Russell 2000 ETF, an estimated $1.57B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Goldman Sachs's largest Q3 2025 buy was Fidelity Enhanced International ETF: 1,911,687 shares worth $67.4M.
- Goldman Sachs added most to Microsoft in Q3 2025, an estimated $4B increase.
- Goldman Sachs's biggest Q3 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $1.57B.
- Goldman Sachs fully exited Ansys in Q3 2025, selling an estimated $564M.
- Goldman Sachs's ten largest holdings make up 22% of its $817B portfolio in Q3 2025.
- Goldman Sachs opened 707 new positions and closed 470 in Q3 2025.
- Goldman Sachs's portfolio value rose 11% quarter-over-quarter to $817B.
Based on Goldman Sachs's 13F filing for Q3 2025, filed 14 Nov 2025.